Mr. Speaker, the debate concerning CCSVI should be based on science, evidence, and improving the quality of life for Canadians with MS, who wonder how the government is going to judge the radically different CCSVI data from the east and west of Canada. Canadians with MS ask that if the debate was about evidence, why did the Minister of Health not meet with CCSVI groups across the country and with Canadians who had been treated to learn of their experience? Why did she not include experts in CCSVI in her scientific expert working group, and why was the decision to kill Bill S-204 was taken eight months before the Senate hearings?
The petitioners are calling on the minister to consult experts, undertake phase three clinical trials on an urgent basis, and require follow-up care.